⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 15, 2024Open Access

Supplementary Figure S4 from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma

Josephine K. Dermawan Sarah Chiang Samuel Singer Bhumika Jadeja Martee L. Hensley William D. Tap Sujana Movva Robert G. Maki Cristina R. Antonescu

View Full Paper

Ask AI

Bookmark

Share

Abstract

Supplementary Figure S4. Disease-specific survival (DSS) for STLMS patients (primary at presentation) from the MSK cohort stratified by tumor size represented by Kaplan-Meier curves. Bottom: Alluvial diagram comparing tumor size versus genomic risk groups in STLMS.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Dermawan et al. (2024) studied this question.

synapsesocial.com/papers/68e6a13db6db643587624df1 https://doi.org/10.1158/1078-0432.25826460

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure S4 from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma2024
2Supplementary Figure S3 from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma2024
3Supplementary Figure S3 from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma2024
4Supplementary Figure S8 from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma2024
5Supplementary Figure S8 from Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma2024